{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:03:22Z","timestamp":1790208202072,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Science and Technology, Korea","award":["NRF-2017M3A9C6032060"],"award-info":[{"award-number":["NRF-2017M3A9C6032060"]}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea","doi-asserted-by":"crossref","award":["2017-615"],"award-info":[{"award-number":["2017-615"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2015K1A4A3046807"],"award-info":[{"award-number":["NRF-2015K1A4A3046807"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although pancreatic islet transplantation therapy is ideal for diabetes patients, several hurdles have prevented it from becoming a standard treatment, including donor shortage and low engraftment efficacy. In this study, we prepared insulin-producing cells trans-differentiated from adult human liver cells as a new islet source. Also, cell sheet formation could improve differentiation efficiency and graft survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Liver cells were expanded in vitro and trans-differentiated to IPCs using adenovirus vectors carrying human genes for\n                      <jats:italic>PDX1<\/jats:italic>\n                      ,\n                      <jats:italic>NEUROD1<\/jats:italic>\n                      , and\n                      <jats:italic>MAFA<\/jats:italic>\n                      . IPCs were seeded on temperature-responsive culture dishes to form cell sheets. Differentiation efficiency was confirmed by \u00df cell-specific gene expression, insulin production, and immunohistochemistry. IPC suspension was injected by portal vein (PV), and IPC sheet was transplanted on the liver surface of the diabetic nude mouse. The therapeutic effect of IPC sheet was evaluated by comparing blood glucose control, weight gain, histological evaluation, and hepatotoxicity with IPC injection group. Also, cell biodistribution was assessed by in vivo\/ex vivo fluorescence image tagging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Insulin gene expression and protein production were significantly increased on IPC sheets compared with those in IPCs cultured on conventional culture dishes. Transplanted IPC sheets displayed significantly higher engraftment efficiency and fewer transplanted cells in other organs than injected IPCs, and also lower liver toxicity, improved blood glucose levels, and weight gain. Immunohistochemical analyses of liver tissue revealed positive staining for PDX1 and insulin at 1, 2, and 4\u2009weeks after IPC transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, cell sheet formation enhanced the differentiation function and maturation of IPCs in vitro. Additionally, parameters for clinical application such as distribution, therapeutic efficacy, and toxicity were favorable. The cell sheet technique may be used with IPCs derived from various cell sources in clinical applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-02080-0","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:03:30Z","timestamp":1609891410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Improvement of the therapeutic capacity of insulin-producing cells trans-differentiated from human liver cells using engineered cell sheet"],"prefix":"10.1186","volume":"12","author":[{"given":"Yu Na","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hye","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-9048","authenticated-orcid":false,"given":"In Kyong","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"7","key":"2080_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.amjmed.2016.02.011","volume":"129","author":"S Dholakia","year":"2016","unstructured":"Dholakia S, Mittal S, Quiroga I, Gilbert J, Sharples EJ, Ploeg RJ, Friend PJ. Pancreas transplantation: past, present, future. Am J Med. 2016;129(7):667\u201373.","journal-title":"Am J Med"},{"issue":"24","key":"2080_CR2","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"Group AtCCRiDS","year":"2008","unstructured":"Group AtCCRiDS. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"24","key":"2080_CR3","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"Group TAC","year":"2008","unstructured":"Group TAC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"2080_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129\u201339.","journal-title":"N Engl J Med"},{"issue":"14","key":"2080_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Group TDCaCTR","year":"1993","unstructured":"Group TDCaCTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med"},{"issue":"9131","key":"2080_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"Group UPDSU","year":"1998","unstructured":"Group UPDSU. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","journal-title":"Lancet"},{"issue":"7","key":"2080_CR7","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","volume":"54","author":"EA Ryan","year":"2005","unstructured":"Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54(7):2060\u20139.","journal-title":"Diabetes"},{"issue":"5","key":"2080_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11892-016-0729-3","volume":"16","author":"PA Lysy","year":"2016","unstructured":"Lysy PA, Corritore E, Sokal EM. New insights into diabetes cell therapy. Curr Diab Rep. 2016;16(5):38.","journal-title":"Curr Diab Rep"},{"key":"2080_CR9","first-page":"252387","volume":"2011","author":"I Meivar-Levy","year":"2011","unstructured":"Meivar-Levy I, Sapir T, Berneman D, Weissbach T, Polak-Charcon S, Ravassard P, Tzakis AG, Mor E, Ricordi C, Ferber S. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin-producing cells. J Transp Secur. 2011;2011:252387.","journal-title":"J Transp Secur"},{"issue":"5907","key":"2080_CR10","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1126\/science.1161431","volume":"322","author":"KS Zaret","year":"2008","unstructured":"Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science. 2008;322(5907):1490\u20134.","journal-title":"Science"},{"issue":"22","key":"2080_CR11","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1073\/pnas.0405277102","volume":"102","author":"T Sapir","year":"2005","unstructured":"Sapir T, Shternhall K, Meivar-Levy I, Blumenfeld T, Cohen H, Skutelsky E, Eventov-Friedman S, Barshack I, Goldberg I, Pri-Chen S, et al. Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A. 2005;102(22):7964\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7213","key":"2080_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nature07314","volume":"455","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627\u201332.","journal-title":"Nature"},{"issue":"1","key":"2080_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/gt.2013.50","volume":"21","author":"A Banga","year":"2014","unstructured":"Banga A, Greder LV, Dutton JR, Slack JM. Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist. Gene Ther. 2014;21(1):19\u201327.","journal-title":"Gene Ther"},{"issue":"2","key":"2080_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087812","volume":"9","author":"D Berneman-Zeitouni","year":"2014","unstructured":"Berneman-Zeitouni D, Molakandov K, Elgart M, Mor E, Fornoni A, Dominguez MR, Kerr-Conte J, Ott M, Meivar-Levy I, Ferber S. The temporal and hierarchical control of transcription factors-induced liver to pancreas transdifferentiation. PLoS One. 2014;9(2):e87812.","journal-title":"PLoS One"},{"key":"2080_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jconrel.2014.05.024","volume":"190","author":"K Matsuura","year":"2014","unstructured":"Matsuura K, Utoh R, Nagase K, Okano T. Cell sheet approach for tissue engineering and regenerative medicine. J Control Release. 2014;190:228\u201339.","journal-title":"J Control Release"},{"issue":"5","key":"2080_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"AM Shapiro","year":"2017","unstructured":"Shapiro AM, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13(5):268\u201377.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2080_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nprot.2006.63","volume":"1","author":"Z Medarova","year":"2006","unstructured":"Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc. 2006;1(1):429\u201335.","journal-title":"Nat Protoc"},{"issue":"10","key":"2080_CR18","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","volume":"48","author":"W Bennet","year":"1999","unstructured":"Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 1999;48(10):1907\u201314.","journal-title":"Diabetes"},{"issue":"2","key":"2080_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/03009734000000059","volume":"105","author":"W Bennet","year":"2000","unstructured":"Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105(2):125\u201333.","journal-title":"Ups J Med Sci"},{"issue":"4\u20136","key":"2080_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000080341","volume":"14","author":"RH Lee","year":"2004","unstructured":"Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004;14(4\u20136):311\u201324.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"2080_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065711","volume":"8","author":"C Zhang","year":"2013","unstructured":"Zhang C, Suckow AT, Chessler SD. Altered pancreatic islet function and morphology in mice lacking the Beta-cell surface protein neuroligin-2. PLoS One. 2013;8(6):e65711.","journal-title":"PLoS One"},{"issue":"12","key":"2080_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/ten.tec.2015.0035","volume":"21","author":"M Hirabaru","year":"2015","unstructured":"Hirabaru M, Kuroki T, Adachi T, Kitasato A, Ono S, Tanaka T, Matsushima H, Sakai Y, Soyama A, Hidaka M, et al. A method for performing islet transplantation using tissue-engineered sheets of islets and mesenchymal stem cells. Tissue Eng Part C Methods. 2015;21(12):1205\u201315.","journal-title":"Tissue Eng Part C Methods"},{"key":"2080_CR23","doi-asserted-by":"crossref","unstructured":"Choi J, Woo HN, Ju EJ, Jung J, Chung HK, Park J, Park SS, Shin SH, Park HJ, Lee JS, et al. Immunocytes as a biocarrier to delivery therapeutic and imaging contrast agents to tumors. J Nanomater. 2012.","DOI":"10.1155\/2012\/863704"},{"issue":"4","key":"2080_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10238-014-0319-0","volume":"15","author":"XR Guo","year":"2015","unstructured":"Guo XR, Wang XL, Li MC, Yuan YH, Chen Y, Zou DD, Bian LJ, Li DS. PDX-1 mRNA-induced reprogramming of mouse pancreas-derived mesenchymal stem cells into insulin-producing cells in vitro. Clin Exp Med. 2015;15(4):501\u20139.","journal-title":"Clin Exp Med"},{"issue":"2","key":"2080_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/jcp.21615","volume":"218","author":"SP Raikwar","year":"2009","unstructured":"Raikwar SP, Zavazava N. Insulin producing cells derived from embryonic stem cells: are we there yet? J Cell Physiol. 2009;218(2):256\u201363.","journal-title":"J Cell Physiol"},{"issue":"5","key":"2080_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jmcb\/mju029","volume":"6","author":"HM Shahjalal","year":"2014","unstructured":"Shahjalal HM, Shiraki N, Sakano D, Kikawa K, Ogaki S, Baba H, Kume K, Kume S. Generation of insulin-producing \u03b2-like cells from human iPS cells in a defined and completely xeno-free culture system. J Mol Cell Biol. 2014;6(5):394\u2013408.","journal-title":"J Mol Cell Biol"},{"issue":"11","key":"2080_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ncpendmet0647","volume":"3","author":"PC Butler","year":"2007","unstructured":"Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 2007;3(11):758\u201368.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"2080_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40139-015-0068-0","volume":"3","author":"C Cavelti-Weder","year":"2015","unstructured":"Cavelti-Weder C, Li W, Zumsteg A, Stemann M, Yamada T, Bonner-Weir S, Weir G, Zhou Q. Direct reprogramming for pancreatic beta-cells using key developmental genes. Curr Pathobiol Rep. 2015;3(1):57\u201365.","journal-title":"Curr Pathobiol Rep"},{"issue":"2","key":"2080_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.arr.2013.01.001","volume":"12","author":"J Shen","year":"2013","unstructured":"Shen J, Cheng Y, Han Q, Mu Y, Han W. Generating insulin-producing cells for diabetic therapy: existing strategies and new development. Ageing Res Rev. 2013;12(2):469\u201378.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2080_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13287-017-0694-z","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Liu Q, Zhou Z, Ikeda Y. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration. Stem Cell Res Ther. 2017;8(1):240.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"2080_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BJ20111678","volume":"442","author":"E Akinci","year":"2012","unstructured":"Akinci E, Banga A, Greder LV, Dutton JR, Slack JM. Reprogramming of pancreatic exocrine cells towards a beta (beta) cell character using Pdx1, Ngn3 and MafA. Biochem J. 2012;442(3):539\u201350.","journal-title":"Biochem J"},{"key":"2080_CR32","volume-title":"Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation","author":"J Ren","year":"2007","unstructured":"Ren J, Jin P, Wang E, Liu E, Harlan D, Li X, Stroncek D. Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation, vol. 5; 2007."},{"issue":"2","key":"2080_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4093\/dmj.2011.35.2.119","volume":"35","author":"YH You","year":"2011","unstructured":"You YH, Ham DS, Park HS, Rhee M, Kim JW, Yoon KH. Adenoviruses expressing PDX-1, BETA2\/NeuroD and MafA induces the transdifferentiation of porcine neonatal pancreas cell clusters and adult pig pancreatic cells into beta-cells. Diabetes Metab J. 2011;35(2):119\u201329.","journal-title":"Diabetes Metab J"},{"issue":"12","key":"2080_CR34","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1128\/MCB.25.12.4969-4976.2005","volume":"25","author":"C Zhang","year":"2005","unstructured":"Zhang C, Moriguchi T, Kajihara M, Esaki R, Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol. 2005;25(12):4969\u201376.","journal-title":"Mol Cell Biol"},{"issue":"51","key":"2080_CR35","doi-asserted-by":"publisher","first-page":"49903","DOI":"10.1074\/jbc.M206796200","volume":"277","author":"K Kataoka","year":"2002","unstructured":"Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem. 2002;277(51):49903\u201310.","journal-title":"J Biol Chem"},{"issue":"1","key":"2080_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1677\/jme.0.0320009","volume":"32","author":"K Kataoka","year":"2004","unstructured":"Kataoka K, Shioda S, Ando K, Sakagami K, Handa H, Yasuda K. Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. J Mol Endocrinol. 2004;32(1):9\u201320.","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"2080_CR37","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1073\/pnas.0306233101","volume":"101","author":"TA Matsuoka","year":"2004","unstructured":"Matsuoka TA, Artner I, Henderson E, Means A, Sander M, Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A. 2004;101(9):2930\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2080_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrendo.2016.147","volume":"12","author":"SS Roscioni","year":"2016","unstructured":"Roscioni SS, Migliorini A, Gegg M, Lickert H. Impact of islet architecture on beta-cell heterogeneity, plasticity and function. Nat Rev Endocrinol. 2016;12(12):695\u2013709.","journal-title":"Nat Rev Endocrinol"},{"key":"2080_CR39","doi-asserted-by":"publisher","first-page":"621249","DOI":"10.1155\/2013\/621249","volume":"2013","author":"P Meda","year":"2013","unstructured":"Meda P. Protein-mediated interactions of pancreatic islet cells. Scientifica. 2013;2013:621249.","journal-title":"Scientifica"},{"issue":"6","key":"2080_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/cell.2010.0030","volume":"12","author":"S Gefen-Halevi","year":"2010","unstructured":"Gefen-Halevi S, Rachmut IH, Molakandov K, Berneman D, Mor E, Meivar-Levy I, Ferber S. NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming. Cell Reprogram. 2010;12(6):655\u201364.","journal-title":"Cell Reprogram"},{"issue":"13","key":"2080_CR41","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/S0142-9612(03)00110-8","volume":"24","author":"T Shimizu","year":"2003","unstructured":"Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials. 2003;24(13):2309\u201316.","journal-title":"Biomaterials"},{"issue":"37","key":"2080_CR42","first-page":"5145","volume":"18","author":"R Takagi","year":"2012","unstructured":"Takagi R, Yamato M, Kanai N, Murakami D, Kondo M, Ishii T, Ohki T, Namiki H, Yamamoto M, Okano T. Cell sheet technology for regeneration of esophageal mucosa. World J Gastroenterol. 2012;18(37):5145\u201350.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2080_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"2080_CR44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","volume":"50","author":"EA Ryan","year":"2001","unstructured":"Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001;50(4):710\u20139.","journal-title":"Diabetes"},{"issue":"19","key":"2080_CR45","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMc1613959","volume":"376","author":"DA Baidal","year":"2017","unstructured":"Baidal DA, Ricordi C, Berman DM, Alvarez A, Padilla N, Ciancio G, Linetsky E, Pileggi A, Alejandro R. Bioengineering of an intraabdominal endocrine pancreas. N Engl J Med. 2017;376(19):1887\u20139.","journal-title":"N Engl J Med"},{"key":"2080_CR46","first-page":"211","volume":"7","author":"A Bruni","year":"2014","unstructured":"Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014;7:211\u201323.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"2080_CR47","first-page":"37","volume":"59","author":"KL Stocking","year":"2009","unstructured":"Stocking KL, Jones JC, Everds NE, Buetow BS, Roudier MP, Miller RE. Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells. Comp Med. 2009;59(1):37\u201345.","journal-title":"Comp Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-02080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:08:57Z","timestamp":1609891737000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-02080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-02080-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18445\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18445\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18445\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This animal study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC No. 2015-12-133) Asan Institute for Life Sciences. The committee abides by the Institute of Laboratory Animal Resources (ILAR) guide. We obtained written informed consent from all the patients who participated in this study. All experiment protocol of human liver cell isolation was carried out according to the guidelines and with the approval of the Institutional Review Board of Asan Medical Center (IRB number: 2014-1182 Seoul, Republic of Korea).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Teruo Okano is a founder and Director of the Scientific Advisory Board of CellSeed Inc., which has licenses for certain cell sheet-related technologies and patents from Tokyo Women\u2019s Medical University. Ms. Yu Na Lee, Ms. Hye-Jin Yi, Ms. Eun Hye Seo, Ms. Jooyun Oh, Dr. Song Lee, Dr. Sarah Ferber, Dr. In Kyong Shim, and Dr. Song Cheol Kim declare no potential conflict of interest. The authors declare that there are no other financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}